DES

(redirected from Drug-eluting stent)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

DES

Abbreviation for "Delivered Ex Ship."

Delivered Ex Ship

In international commerce, an agreement between a buyer and a seller in which the seller must bear all costs and risks of transporting a good until it has arrived at a port and has been made available for the buyer or his/her agent to retrieve it. That is, the seller has total responsibility while the good is being shipped overseas. The seller must pay the shipping company and purchase insurance for the good. See also: Incoterm.
References in periodicals archive ?
Reconstruction of the arteries through surgery is the primary treatment, but drug-eluting stents could offer a less invasive option.
Our results clearly show that drug-eluting stents are indeed safe," said Pamela Douglas, M.
A 49-year-old male was scheduled for colonoscopy 630 days after having a paclitaxel drug-eluting stent inserted in his right coronary artery for management of an inferior myocardial infarction.
the two FDA-approved drug-eluting stents, when used for on-label indications, are reasonably sate and effective," Bram Zuckerman, director of CDRH's cardiovascular device review division, told
It is completely unclear how cardiologists should manage restenosis within a drug-eluting stent.
Forthe study, researchers examined 80 patients, roughly half of whom had vein grafts with drug-eluting stents and the other half who had the same procedure with bare-metal stents.
Two brands of drug-eluting stents, Cypher and Taxus, currently compete in the U.
Receives Approval for its Drug-Eluting Stent, "Endeavor" In Canada II-38 Boston Scientific to Market TAXUS[R] Liberte[R] Stent System in Canada II-38 Abbott Applies for Approval of XIENCE[TM] V in Japan II-38 Medinol Achieves CE Mark Approval for Presillion[TM] Cobalt Chromium Coronary Stent System II-39 Iberhospitex Receives Spanish Approval to Sell Palau Pharma's "Active" Coronary Stent II-39 Clearstream's Intrepide Drug Eluting Stent of Clearstream Receives CE mark approval II-39 Terumo Introduces Its Drug-Eluting Stent in Germany and Marks Its European Entry II-39 Tryton Medical's Side-Branch Stent Achieves CE Mark Approval II-39 CV Therapeutics Offers its Stent Coating Technology to Medlogics Device Corporation II-40 Abbott's 2.
Predictions that drug-eluting stents will prove harmful in the long run do us all an injustice by impairing the development of this important new treatment.
It makes sense to change coatings if a patient didn't respond to a drug-eluting stent the first time," Dr.
In March 2007, Medtronic released two-year results from the largest and longest drug-eluting stent clinical trial program to date.